RANKINGS

POPULAR STOCKS

Natera, Inc.

NasdaqGS:NTRA

Location

United States

Market Cap

USD 22.96 B

Share Price

USD 168.17

Avg Daily Volume

1,477,653

Change (1 day)

2.44%

Change (1 year)

50.97%

Change (YTD)

6.24%

Natera, Inc. Total Liabilities for the year ending December 31, 2024: USD 465.31 M

Natera, Inc. Total Liabilities is USD 465.31 M for the year ending December 31, 2024, a -31.20% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
  • Natera, Inc. Total Liabilities for the year ending December 31, 2023 was USD 676.37 M, a -1.79% change year over year.
  • Natera, Inc. Total Liabilities for the year ending December 31, 2022 was USD 688.73 M, a 18.10% change year over year.
  • Natera, Inc. Total Liabilities for the year ending December 31, 2021 was USD 583.18 M, a 30.78% change year over year.
  • Natera, Inc. Total Liabilities for the year ending December 31, 2020 was USD 445.92 M, a 46.71% change year over year.
Key data
Date Total Liabilities Shareholders' Equity Cash and Short-Term Investments Receivables
Market news
NasdaqGS: NTRA

Natera, Inc.

CEO Mr. Steven Leonard Chapman
IPO Date July 1, 2015
Location United States
Headquarters 13011 McCallen Pass Building A
Employees 4,424
Sector 🏥 Health Care
Industries
Clinical Trials
📊 Big Data
🧬 Biotechnology
🩺 Medical Instruments
💻 Telehealth
Description

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.

Similar companies

BSX

Boston Scientific Corporation

USD 104.58

0.28%

SHL.DE

Siemens Healthineers AG

USD 54.80

0.08%

GEHC

GE HealthCare Technologies Inc.

USD 74.86

2.90%

LH

Laboratory Corporation of America Holdings

USD 256.98

-0.66%

BAX

Baxter International Inc.

USD 30.50

-0.36%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 37.60

0.25%

ICLR

ICON Public Limited Company

USD 146.75

0.58%

RGC

Regencell Bioscience Holdings Limited

USD 20.19

-7.09%

ASND

Ascendis Pharma A/S

USD 172.95

-0.03%

EXAS

Exact Sciences Corporation

USD 51.81

-0.21%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.12%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.86

-1.68%

GH

Guardant Health, Inc.

USD 50.03

0.26%

DIA.MI

DiaSorin S.p.A.

USD 109.98

0.72%

688617.SS

APT Medical Inc.

USD 41.08

1.04%

LNTH

Lantheus Holdings, Inc.

USD 80.74

0.24%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.25%

TMDX

TransMedics Group, Inc.

USD 130.06

1.15%

ADMA

ADMA Biologics, Inc.

USD 18.40

4.54%

LAURUSLABS.NS

Laurus Labs Limited

USD 7.94

1.94%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.69

-0.60%

INSP

Inspire Medical Systems, Inc.

USD 129.71

-1.74%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.16%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.96

0.12%

PFIZER.NS

Pfizer Limited

USD 66.25

2.27%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.91

0.75%

ERIS.NS

Eris Lifesciences Limited

USD 18.88

-0.23%

LIVN

LivaNova PLC

USD 45.80

-0.15%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.99

0.21%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.12

-2.57%

VCYT

Veracyte, Inc.

USD 26.81

1.36%

BAVA.CO

Bavarian Nordic A/S

USD 26.70

1.60%

0853.HK

MicroPort Scientific Corporation

USD 1.11

1.19%

VITR.ST

Vitrolife AB (publ)

USD 14.53

2.24%

NVCR

NovoCure Limited

USD 17.10

-1.33%

QDEL

QuidelOrtho Corporation

USD 28.70

2.10%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.09

3.84%

HRMY

Harmony Biosciences Holdings, Inc.

USD 31.86

0.92%

ADPT

Adaptive Biotechnologies Corporation

USD 12.16

1.50%

CERT

Certara, Inc.

USD 11.42

5.16%

ARQT

Arcutis Biotherapeutics, Inc.

USD 14.40

-0.48%

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

USD 3.13

0.29%

688289.SS

Sansure Biotech Inc.

USD 2.85

0.72%

INDGN.NS

Indegene Limited

USD 6.71

-0.64%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.66

-0.44%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

0.52%

002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

USD 1.80

-0.18%

605507.SS

Guobang Pharma Ltd.

USD 2.75

0.44%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.27

0.36%

ABBV

AbbVie Inc.

USD 186.79

0.76%

StockViz Staff

June 27, 2025

Any question? Send us an email